NRIX vs RL · rev $54.5M vs P/E 24, rev $8.11B
Nurix Therapeutics Inc (NRIX) versus Ralph Lauren Corp Class A (RL) — a side-by-side from cached financials, not a winner call.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
NRIX currently screens at market cap $1.77B. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Not investment advice. Open the NRIX and RL stock pages for the full models.
Not investment advice.